Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

Clinical trial NCT05266586 · COMPLETED

Trial details

NCT number: NCT05266586
Sponsor: NewAmsterdam Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemias High Cholesterol Hypercholesterolemia

Start date: 2022-03-09
Primary completion: 2022-08-12
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.